Consult a physician in case of accidental ingestion by humans.There is currently no legal information available for this drug.There are currently no FDA safety alerts available for this drug.There is currently no manufacturer warning information available for this drug.There are currently no FDA labeling changes available for this drug.There is currently no usage information available for this product. There are other possible severe side effects specifically from Strattera. The dosing level, as well as frequency, will depend on the severity of the dog's condition and body weight.Vetmedin is generally given for the rest of the dog's life once treatment has started. Pimobendan exerts a stimulatory myocardial effect by a dual mechanism of action consisting of an increase in calcium sensitivity of cardiac myofilaments and inhibition of phosphodiesterase (Type III). Among STRATTERA-treated patients, irritability (0.3%, N=5); STRATTERA has not been systematically evaluated in pediatric patients with Commonly observed adverse reactions associated with the use of STRATTERA (incidence of 2% or greater) and not observed at an equivalent incidence among placebo-treated patients (STRATTERA incidence greater than placebo) are listed in Table 2. Copyright 2020 Leaf Group Ltd. / Leaf Group Media, All Rights Reserved. However in most cases these side effects are generally not severe. Vomiting is a rare side effect of the drug; diarrhea and loss of appetite may occur. Vetmedin is regarded as a very safe drug, although some minor side effects are sometimes noticed, the majority of which include loss of appetite, diarrhoea, lethargy, vomiting, and overall weakness. Low Energy 11. The abbreviated term ADHD denotes the condition commonly known as:

These side effects of pimobendan may progressively diminish with continued use of this medication. What will it do for me? Pimobendan exhibits vasodilating activity by inhibiting phosphodiesterase III activity. Strattera (atomoxetine) is a selective norepinephrine Strattera dose ranges from 40mg/day to 100mg/day given in 1-2 divided doses.Strattera may cause severe liver injury. Are there any other precautions or warnings for this medication? Strattera's most common side effects are stomach upset (including nausea, vomiting, dyspepsia or indigestion, appetite decrease, fatigue, and mood swings). There is no cure for congestive heart failure; therefore, the medication is used to aid the heart and make it as productive as possible.Vetmedin is regarded as a very safe drug, although some minor side effects are sometimes noticed, the majority of which include loss of appetite, diarrhoea, lethargy, vomiting, and overall weakness.Some more serious side effects of Vetmedin are shortness of breath and ataxia (uncoordinated neurological movements). SIDE EFFECTS Clinical Trials Experience. The tablets are scored and the calculated dosage should be provided to the nearest half tablet increment.This website is intended for informational and entertainment purposes only and is not intended to replace any professional medical advice.This field is for validation purposes and should be left unchanged. For all studies, (including open-label and long-term studies), 6.3% of extensive metabolizer (EM) patients and 11.2% of poor metabolizer (PM) patients discontinued because of an adverse reaction. If experienced, these tend to have a Severe expression 1. Painful Periods If experienced, these tend to have a Less Severe expression 1. Stomach Cramps 12. What other drugs could interact with this medication? Results were similar in the Additional data from ADHD clinical trials (controlled and uncontrolled) has shown that approximately 5 to 10% of pediatric patients experienced potentially clinically important changes in heart rate (≥20 beats per min) or blood pressure (≥15 to 20 mm The following adverse reactions occurred in at least 2% of child and adolescent CYP2D6 PM patients and were statistically significantly more frequent in PM patients compared with CYP2D6 EM patients: insomnia (11% of PMs, 6% of EMs); weight decreased (7% of PMs, 4% of EMs); constipation (7% of PMs, 4% of EMs); depression1 (7% of PMs, 4% of EMs); In the acute adult placebo-controlled trials, 11.3% (61/541) atomoxetine subjects and 3.0% (12/405) placebo subjects discontinued for adverse reactions. 6. Less serious side effects do not require you to stop the medication, but you should check with your vet if any symptoms occur that worry you or seem unusual.

The side effects listed below are not experienced by everyone who takes this medication. Vetmedin's scored pills come in 1.25 mg, 2.5 mg, 5 mg, and 10 mg. Each bottle comes with 50 counts of pills. Other potential side effects include loss of coordination, seizures and uneasiness. In these clinical trials, no poor metabolizers (0/43) reported seizures compared to 0.1% (1/705) for extensive metabolizers.Commonly observed adverse reactions associated with the use of STRATTERA (incidence of 2% or greater) and not observed at an equivalent incidence among placebo-treated patients (STRATTERA incidence greater than placebo) are listed in Table 4. Unless otherwise specified, these adverse reactions have occurred in adults and children and adolescents. Accordingly, estimates of the incidence of untoward sexual experience and performance cited in product labeling are likely to underestimate the actual incidence. Chronic Trouble Sleeping 2. See below for a comprehensive list of adverse effects. Common side effects of Strattera include: trouble sleeping (insomnia), dry mouth, cough, decreased appetite, upset stomach, nausea or vomiting, dizziness, drowsiness, irritability, constipation, skin rash, itching, increased menstrual cramps, and sexual side effects including impotence,


Not for use in humans.

If you are concerned about side effects, discuss the risks and benefits of this medication with your doctor. More Serious Side Effects.
At 3 and 5 times the recommended dosage, administered over a 6-month period of time, pimobendan caused an exaggerated hemodynamic response in the normal dog heart, which was associated with cardiac pathology (See Not for use in humans.

In the clinical development program, seizures were reported on 0.1% (1/748) of adult patients.